Medium-Chain Triglyceride Synthesis via Vacuum Esterification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing medium-chain triglycerides (MCTs) face challenges in achieving high yield and purity, particularly in large-scale production, due to incomplete esterification and product loss during purification, which complicates the process and makes it difficult to obtain triglycerides with purity exceeding 75%.

Innovation Solution

A method involving the reaction of glycerol with medium-chain length fatty acids in the presence of a divalent or trivalent metal cation catalyst under partial vacuum at elevated temperatures, allowing for high yield and purity (>99.5%) triglyceride formation without the need for solvents, using catalysts like tungsten oxide, calcium oxide, or zinc oxide, and incorporating recovery steps for crystallization and purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional esterification methods are used to synthesize MCTs, then the reaction can proceed under standard conditions, but the yield and purity do not exceed 75% due to incomplete esterification and product loss during workup and purification

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent applies parameter changes by conducting the esterification reaction under partial vacuum conditions and at elevated temperatures (140-260°C), which shifts the equilibrium toward complete esterification and enables high yield and purity triglyceride formation without requiring complex purification steps

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent eliminates the need for complex purification processes by taking out the water formed during esterification through partial vacuum conditions, allowing the reaction to proceed to completion and directly producing high purity triglycerides that can be isolated by simple filtration and solvent removal

Inventive Principle:
Principle #2Taking out (Extraction)

2Manufacturing precision

If conventional purification methods like decolourization and chromatographic purification/distillation are used, then product purity can be improved, but the process complexity increases and makes large-scale synthesis difficult

Engineering Contradiction:
ImprovepurityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent removes the need for complex purification equipment by extracting water during the reaction itself through partial vacuum conditions, allowing direct isolation of high purity triglycerides by simple filtration and solvent evaporation rather than requiring chromatographic or distillation equipment

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

By changing the reaction conditions to partial vacuum and elevated temperature, the patent transforms the purification requirement into an inherent feature of the reaction process, where water removal drives complete esterification and the product precipitates in high purity form

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If conventional esterification methods are used, then the reaction can proceed under standard atmospheric conditions, but incomplete esterification occurs and product is lost during workup and purification

Engineering Contradiction:
Improveease of synthesisVSAvoidproduct loss
Core Design Contradiction:
Ease of operationVSLoss of substance

Solution Approach 1:

The patent applies parameter changes by conducting the reaction under partial vacuum conditions which continuously remove water formed during esterification, shifting the equilibrium toward complete conversion and eliminating product loss during workup since the triglyceride precipitates directly in high purity form

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves high yield (75-95%) and purity (99.5%) of medium-chain triglycerides, simplifying the large-scale synthesis and eliminating the need for complex purification processes like chromatography and distillation, while also enabling the use of these triglycerides as excipients in pharmaceutical formulations to enhance solubility of poorly water-soluble drugs.

Implementation Method 1

reacting the mixture of step (a) with a divalent or trivalent metal cation catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

heating at a temperature of 160°C or more, under partial vacuum, for a period of time sufficient to form the triglyceride

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 3

heating at a temperature of 160°C or more, under partial vacuum, for a period of time sufficient to form the triglyceride, wherein said partial vacuum is from 1 to 20 mm Hg

Methodology Applied
Scientific EffectVacuum: Vacuum

Data Source

PatentEP2819989B1Method for the preparation of triglycerides of medium-chain length fatty acids
Publication Date: 2019.01.16 PROMETIC PHARMA SMT LIMITED
  • EP2819989B1 patent drawing

AI summary

A method is disclosed for the preparation of glycerol esters (triglycerides) of medium-chain length monocarboxylic fatty acids which consists of the reaction of the precursor free fatty acid and glycerol in the presence of a catalyst under partial vacuum. The process preferably uses a metal catalyst such as an oxide or a chloride of tungsten, molybdenum, calcium, zinc, chromium or magnesium. The method of the invention allows the preparation in high yield and high purity (>99.5%) of the final triglyceride. The present method allows the formation of triglycerides without solvent. Are also contemplated, the triglyceride obtained by the method, and the pharmaceutical composition containing the triglyceride as an excipient or as an active ingredient.